We have an investment in and joint venture with Panaxia Global, a pharmaceutical company based in Israel that specializes in medical cannabis R&D and manufacturing. Panaxia was founded in 2009, and belongs to a corporate group established over 40 years ago that includes Luminera, Maayan Haim pharmaceutical compounding facility and Tree of Life Pharma. The group’s companies integrate extensive knowledge in pharmacy and chemistry along with years of pharmaceutical experience, from R&D via product registration and manufacturing to marketing and sales.
This combined expertise from multiple pharmaceutical companies enabled Panaxia to develop and apply stringent GMP standards for their facilities and processes, from the early planning stages to end-product quality control. Operating at pharma-level standards, Panaxia creates a modular lab within a facility that contains stabilized clean-room environments for cannabis manufacturing. Their extraction process is carried out in ethanol and includes a decarboxylation step. The final oil product formulation includes pharmaceutical grade excipients to provide preservation and prevent oxidation of the products. The entire process is conducted under quality control restraints and there are four in-process-control evaluations performed throughout the chain of production.
Panaxia produces top-tier extraction products with Israeli-based science and operational systems, and they can also do detection and quantification of cannabinoids within their products by using reversed phase HPLC systems equipped with a UV detector. Panaxia’s products are consistent, effective, and accurately dosed at the highest pharmaceutical standard in Israel.
While there are many extraction facilities in California, they do not operate at the level of an Israeli pharmaceutical facility. They are also currently conducting clinical trials with their products, with the hopes of being able to make actual claims on their products within 2 years. Currently, they have 3 cannabis products hitting pharmacy shelves in Israel, the first company ever to do so. Dispensaries in the California market look for product lines that have third-party testing verification and produce consistent results, all of which Panaxia provides and more. Panaxia offers over 65 formulations, including sub-lingual and oral tablets, oils, creams, patches, vapes, suppositories and more.
For more information on Panaxia Global: http://panaxia.co.il/